We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+12.47%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.13B
AUM Growth
+$203M
Cap. Flow
-$12.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
30.3%
Holding
2,428
New
30
Increased
109
Reduced
927
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Financials 10.88%
3 Healthcare 10.85%
4 Consumer Discretionary 9.35%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMRX icon
2226
Immuneering
IMRX
$335M
$8.58K ﹤0.01%
1,167
DC icon
2227
Dakota Gold
DC
$821M
$8.54K ﹤0.01%
3,258
ILPT
2228
Industrial Logistics Properties Trust
ILPT
$609M
$8.53K ﹤0.01%
1,814
-1
-0.1% -$3
PAMT
2229
PAMT Corp
PAMT
$281M
$8.52K ﹤0.01%
410
BFLY icon
2230
Butterfly Network
BFLY
$2.46B
$8.44K ﹤0.01%
7,818
USCB icon
2231
USCB Financial Holdings
USCB
$416M
$8.4K ﹤0.01%
+686
New +$7.82K
LILA icon
2232
Liberty Latin America Class A
LILA
$1.67B
$8.38K ﹤0.01%
1,687
-1,454
-46% -$7.01K
LE icon
2233
Lands' End
LE
$387M
$8.37K ﹤0.01%
+875
New +$6.5K
NXDR
2234
Nextdoor Holdings
NXDR
$998M
$8.28K ﹤0.01%
4,381
-3,794
-46% -$6.69K
NLOP
2235
Net Lease Office Properties
NLOP
$173M
$8.26K ﹤0.01%
+447
New +$7.44K
SCLX icon
2236
Scilex Holding
SCLX
$47.8M
$8.23K ﹤0.01%
+115
New +$5.97K
AOMR
2237
Angel Oak Mortgage REIT
AOMR
$210M
$8.2K ﹤0.01%
+774
New +$7.33K
ATOM icon
2238
Atomera
ATOM
$218M
$8.2K ﹤0.01%
1,169
SKIN icon
2239
SkinHealth Systems
SKIN
$84.8M
$8.15K ﹤0.01%
2,622
-2,197
-46% -$8.24K
WLFC icon
2240
Willis Lease Finance
WLFC
$1.15B
$8.06K ﹤0.01%
495
INTT icon
2241
inTEST
INTT
$178M
$8.02K ﹤0.01%
590
FATE icon
2242
Fate Therapeutics
FATE
$312M
$8.02K ﹤0.01%
2,144
-2,381
-53% -$5.62K
STOK icon
2243
Stoke Therapeutics
STOK
$2.1B
$7.97K ﹤0.01%
1,515
CMT icon
2244
Core Molding Technologies
CMT
$233M
$7.93K ﹤0.01%
428
KLXE icon
2245
KLX Energy Services
KLXE
$35.7M
$7.93K ﹤0.01%
704
SB icon
2246
Safe Bulkers
SB
$779M
$7.86K ﹤0.01%
1,999
-1,867
-48% -$6.57K
AGEN
2247
Agenus
AGEN
$309M
$7.84K ﹤0.01%
473
-466
-50% -$7.72K
SPRY icon
2248
ARS Pharmaceuticals
SPRY
$592M
$7.83K ﹤0.01%
1,428
MACK
2249
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$7.79K ﹤0.01%
581
PDSB icon
2250
PDS Biotechnology
PDSB
$13.2M
$7.69K ﹤0.01%
1,547

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2023 Portfolio in Review

As of Q4 2023, Metropolitan Life Insurance Company (MetLife) held 2,428 positions worth $2.13B, up 11% from $1.93B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4.7%. Metropolitan Life Insurance Company (MetLife) opened 30 new positions and exited 85, leaving the 2,428-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2023 buy was iShares Broad USD Investment Grade Corporate Bond ETF: 578,568 shares worth $29.7M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $38.1M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2023 reduction was Apple, cutting an estimated $2.39M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Vanguard Total Bond Market in Q4 2023, selling an estimated $72.5M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $2.13B portfolio in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 30 new positions and closed 85 in Q4 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 11% quarter-over-quarter to $2.13B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.